ArticleBiogerontology2024

The SGLT2 inhibitor empagliflozin inhibits skeletal muscle fibrosis in naturally aging male mice through the AMPKα/MMP9/TGF-β1/Smad pathway.

Qixuan Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.